Your account is not claimed yet. You can sign up with ORCID to claim your account.

Pelin Telkoparan-Akillilar

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Venues

3 Biotech

Biomedicines

International journal of molecular sciences

BioFactors (Oxford, England)

Yüksek İhtisas Üniversitesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yüksek İhtisas Üniversitesi Aug 1o 2015

Turkey

Yard. Doc. Dr :: Tıbbi Biyoloji

Publications

Okan Onar, Pelin Telkoparan-Akillilar, Ozlem Yildirim
Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech 13 (2) (2023)
Gazmend Temaj, Pelin Telkoparan-Akillilar, Nexhibe Nuhii, Silvia Chichiarelli, Sarmistha Saha, Sarmistha Saha
Recoding of Nonsense Mutation as a Pharmacological Strategy. Biomedicines 11 (3) (2023)
Gazmend Temaj, Pelin Telkoparan-Akillilar, Nexhibe Nuhii, Silvia Chichiarelli, Sarmistha Saha, Sarmistha Saha
Recoding of Nonsense Mutation as a Pharmacological Strategy. Biomedicines 11 (3) (2023)
Okan Onar, Pelin Telkoparan-Akillilar, Ozlem Yildirim
Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech 13 (2) (2023)
Okan Onar, Pelin Telkoparan-Akillilar, Ozlem Yildirim
Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech 13 (2) (2023)
Okan Onar, Pelin Telkoparan-Akillilar, Ozlem Yildirim
Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech 13 (2) (2023)
Melford Chuka Egbujor, Elisabetta Profumo, Elisabetta Profumo, Pelin Telkoparan-Akillilar, Sarmistha Saha
An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects. International journal of molecular sciences 23 (15) (2022)
Emiliano Panieri, Pelin Telkoparan-Akillilar, Sarmistha Saha
NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer. BioFactors (Oxford, England) (2022)
Pelin Telkoparan-Akillilar, Emiliano Panieri, Dilek Cevik, Sibel Suzen, Sarmistha Saha
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer. Molecules (Basel, Switzerland) 26 (5) (2021)
Pelin Telkoparan-Akillilar, Dilek Cevik
Identification of miR-17, miR-21, miR-27a, miR-106b and miR-222 as endoplasmic reticulum stress-related potential biomarkers in circulation of patients with atherosclerosis. Molecular biology reports 48 (4) (2021)
Emiliano Panieri, Pelin Telkoparan-Akillilar, Sibel Suzen, Sarmistha Saha
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives. Biomolecules 10 (5) (2020)
Pelin Telkoparan-Akillilar, Sibel Suzen, Sarmistha Saha
Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs. International journal of molecular sciences 20 (8) (2019)

Pelin Telkoparan-Akillilar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pelin Telkoparan-Akillilar